Letter from the Editor
Letter from the Editor
The UEG Week 2019 -advancing science - linking people- is arguably the yearly focus point of European gastroenterology bringing together practitioners, top scientists and everyone interested in digestive health. As such, it serves as a true educational hub showcasing key developments in the field and contributing to the postgraduate teaching of gastroenterologists.
This year >13,000 participants from >122 countries contributed to the success of UEG Week 2019. More than 4,000 scientific abstracts were sent to the UEG and the best made the cut and were presented at the UEG Week in Barcelona, Spain. We are looking back at 5 intensive days of scientific interaction, networking and learning. The meeting is unique in that part of the program is offered through online live streaming and this year there were almost 4,200 viewers.
In case you have missed some of the exciting content there is a possibility to go back online as all UEG Week highlight sessions are available on demand. Here, we present the best of the best that was offered from the UEG Week 2019. We have been careful to select the work that is likely to impact your clinical practice and has the potential to influence your clinical thinking.
Best, Joost PH Drenth
Joost PH Drenth is a Hepatologist and the current chair of the Department of Gastroenterology and Hepatology of the Radboudumc, Nijmegen, the Netherlands. He received his medical degree from the University of Maastricht and his PhD (cum laude) at the Radboudumc. He was trained as an Internist and Gastroenterologist at the Radboudumc. He obtained a Royal Netherlands Academy of Art and Sciences fellowship and was a research fellow at the National Institutes of Health, Bethesda, USA. He serves and has served within a number of committees of professional organisations at the national as well as the European level, most notably United European Gastroenterology (Vienna, Austria). He is the chair of the Dutch Society for the study of Liver disease. He is the current editor of the UEG journal. He acts as the pillar head in the European Rare diseases Network (ERN) Liver consortium.
Conflict of Interest Statement:
JD declares that The Radboudumc, on behalf of JD, received honoraria or research grants from Novartis, Otsuka, Merck, Gilead, and Abbvie. JD has served as consultant for Celltrion, Gilead and Abbvie, and has been member of advisory boards of Otsuka, Gilead, and Abbvie.
Top image: @ iStockPhoto: ipopba
Article image: Medicom
The content and interpretation of these conference highlights are the views and comments of the speakers/authors.